4//SEC Filing
Naganathan Girish 4
Accession 0001093557-23-000053
CIK 0001093557other
Filed
Mar 9, 7:00 PM ET
Accepted
Mar 10, 3:59 PM ET
Size
4.9 KB
Accession
0001093557-23-000053
Insider Transaction Report
Form 4
DEXCOM INCDXCM
Naganathan Girish
EVP Chief Technology Officer
Transactions
- Award
Common Stock
2023-03-08$0.00/sh+18,776$19→ 50,225 total
Footnotes (2)
- [F1]Represents a grant of restricted stock units that are exempt from Section 16 b-3 and are subject to vesting in three equal annual installments from the date of grant. Share units represent a contingent right to receive one share of DexCom, Inc. Common Stock.
- [F2]Included in this number are 50,225 unvested restricted stock units, 18,776 of which were granted on March 8, 2023 and shall vest through March 8, 2026, 31,449 of which were granted on November 8, 2022 and shall vest through November 8, 2026.
Documents
Issuer
DEXCOM INC
CIK 0001093557
Entity typeother
Related Parties
1- filerCIK 0001949138
Filing Metadata
- Form type
- 4
- Filed
- Mar 9, 7:00 PM ET
- Accepted
- Mar 10, 3:59 PM ET
- Size
- 4.9 KB